My comment about “allowing” votes was not my thought but a commentary on the previous posters contradictory comments and fickleness.
Obviously it’s a public company. And obviously as I said in a previous comment that despite her having “so few shares” as the previous poster had said, shareholders still voted for her and others to receive their compensation. The same goes for their shares.
As for funding CDMO’si have explained numerous times how that in fact reduces risk, and it’s a contract manufacturer. It was likely shorts that blew up the previous relationship and the long time for the trial that made selling the first CDMO, but they actually funded NWBO, and that arrangement was what blew up when shorts targeted it. Having first management buy out and then the sale to CRL was a positive development for the ecosystem, not some negative rip off. And you don’t know how much she put into that or puts into Advent even.
You’re supposed to make more than you put in and she saved the company and invested when it was necessary to keep a very long effort on track, something that does not always happen for companies like this. So quit the BS hammering of her.
I think you understate what she has put in and of course she is not going to put in the lions share of capital in a biotech as complex and long to validate as this one or any other. That’s just not how any of this works. As if Mark Zuckerberg or Elon Musk put in all the capital in all of their companies to own the equity they owned. Total nonsense.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
AI
